Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01608594
What this trial is testing

Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma

Who this might be right for
Melanoma
Diwakar Davar 30
Testing effectiveness (Phase 2)Looking for participantsNCT07057596
What this trial is testing

Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma

Who this might be right for
Mestastatic Uveal Melanoma
Grupo Español Multidisciplinar de Melanoma 19
Testing effectiveness (Phase 2)WithdrawnNCT04495010
What this trial is testing

Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants

Who this might be right for
Melanoma
Bristol-Myers Squibb
Testing effectiveness (Phase 2)WithdrawnNCT03220009
What this trial is testing

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Who this might be right for
Cervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02211131
What this trial is testing

Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma

Who this might be right for
Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma
Amgen 150
Testing effectiveness (Phase 2)Study completedNCT01341158
What this trial is testing

NAM-Trial: Multiferon in Malignant Melanoma

Who this might be right for
Locoregional Metastases in Malignant Melanoma Stages IIIB/C
University Hospital Tuebingen 42
Testing effectiveness (Phase 2)Study completedNCT02306850
What this trial is testing

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Who this might be right for
Unresectable Malignant NeoplasmMelanomaMetastatic Melanoma+2 more
St. Louis University 10
Early research (Phase 1)Study completedNCT02339324
What this trial is testing

Neoadjuvant Combination Biotherapy With Pembrolizumab and High Dose IFN-alfa2b

Who this might be right for
Melanoma
Yana Najjar 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04722575
What this trial is testing

Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma

Who this might be right for
Melanoma
Fondazione Melanoma Onlus 95
Testing effectiveness (Phase 2)Study completedNCT04401995
What this trial is testing

Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab

Who this might be right for
Melanoma
Diwakar Davar 9
Large-scale testing (Phase 3)Looking for participantsNCT07015190
What this trial is testing

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Who this might be right for
Uveal Melanoma
IDEAYA Biosciences 520
Testing effectiveness (Phase 2)Looking for participantsNCT06240143
What this trial is testing

Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma

Who this might be right for
Melanoma
The Netherlands Cancer Institute 96
Early research (Phase 1)Study completedNCT04274816
What this trial is testing

Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma

Who this might be right for
Cutaneous Melanoma
A.J.M. van den Eertwegh 13
Large-scale testing (Phase 3)Looking for participantsNCT06794775
What this trial is testing

SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
Hildur Helgadottir 128
Testing effectiveness (Phase 2)WithdrawnNCT01216787
What this trial is testing

RO4929097 in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Stage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04013854
What this trial is testing

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

Who this might be right for
Melanoma Stage IIIMelanoma
Abramson Cancer Center at Penn Medicine 67
Testing effectiveness (Phase 2)Looking for participantsNCT06295159
What this trial is testing

Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVAdvanced Melanoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 90
Testing effectiveness (Phase 2)Looking for participantsNCT07349303
What this trial is testing

Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

Who this might be right for
Melanoma (Skin Cancer)
Vastra Gotaland Region 30
Testing effectiveness (Phase 2)UnknownNCT02036086
What this trial is testing

Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases

Who this might be right for
Melanoma
Sunnybrook Health Sciences Centre 24
Testing effectiveness (Phase 2)Study completedNCT02519322
What this trial is testing

Neoadjuvant and Adjuvant Checkpoint Blockade

Who this might be right for
Cutaneous MelanomaMucosal MelanomaOcular Melanoma+8 more
M.D. Anderson Cancer Center 53
Next Page